Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision

• Status: Completed
• Trial end date: 2008-11-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the effect of PEG-400 and Systane on quality of vision after LASIK.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bp Consulting, Inc

Criteria

Inclusion Criteria:

• Males or females > 21 years old

• Scheduled to undergo bilateral LASIK

• Likely to complete all study visits and able to provide informed consent

Exclusion Criteria:

• Prior or current use of topical cyclosporine within the last 1 year

• Known contraindications to any study medication or ingredients

• Ocular disorders

• Active ocular diseases or uncontrolled systemic disease

• Active ocular allergies

• Complications at the time of surgery